Bigotte Vieira, Miguel2025-08-062025-08-062024-07-01Kidney360 . 2024 Jul 1;5(7):936-937. doi: 10.34067/KID.0000000000000454.http://hdl.handle.net/10400.17/5137engHCC NEFHumansCognition* / drug effectsGraft Rejection / immunologyGraft Rejection / prevention & controlImmunosuppressive Agents* / adverse effectsImmunosuppressive Agents* / pharmacokineticsKidney Transplantation*Tacrolimus* / pharmacokineticsTacrolimus* / therapeutic useTransplant Recipients / psychologyReducing Tacrolimus Levels to Improve Cognitive Function in Kidney Transplant Recipients.editorialKidney360 . 2024 Jul 1;5(7):936-937. doi: 10.34067/KID.0000000000000454.39052471